RSS
|
Login
|
Register
HOME
SPECIALTY
Hematology-Oncology
Long Term Care
Nurse Practitioners
OB/GYN
Pharmacists
Physician Assistants
Primary Care Physicians
Residents
Urologists
THERAPEUTIC CATEGORIES
BRAND
GENERIC
COMPARE
NEWS
Drug News
Drugs in the Pipeline
Drug Safety Alerts and Recalls
New Drug Products
Polls & Surveys
Newsletters
News from Haymarket Journals
RESOURCES
Alerts (Sponsored)
Clinical Charts
Common Medical Abbreviations
Company
Drug Monograph Format
FDA Orange Book
Pharmacology Notes
Professional Associations
Video
Blogs
MPR Publications
Customer Service
Online Banner Ad Specs
Subscribe
DOWNLOAD
CME
JOBS
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Home
>
Therapeutic Categories
>
Pain & Pyrexia
> Migraine and headache
Pain & Pyrexia
»
Migraine and headache
Select All |
Compare
|
Add to Clipboard
|
View Clipboard
Name
Compare
ADVIL MIGRAINE
compare
AMERGE
compare
AXERT
compare
CAFERGOT
compare
CAFERGOT SUPPOSITORIES
compare
D.H.E. 45
compare
DEPAKOTE
compare
DEPAKOTE ER
compare
DOLGIC PLUS
compare
ESGIC
compare
ESGIC-PLUS
compare
EXCEDRIN MIGRAINE
compare
FIORICET
compare
FIORICET w. CODEINE
compare
FIORINAL
compare
FIORINAL w. CODEINE
compare
FROVA
compare
IMITREX INJECTION
compare
IMITREX NASAL SPRAY
compare
IMITREX TABLETS
compare
INDERAL
compare
INDERAL LA
compare
MAXALT
compare
MAXALT-MLT
compare
MIDRIN
compare
MIGRANAL
compare
MIGRATEN
compare
MOTRIN MIGRAINE PAIN
compare
PHRENILIN
compare
RELPAX
compare
STAVZOR
compare
SUMAVEL DOSEPRO
compare
Timolol maleate
compare
TOPAMAX SPRINKLE CAPS
compare
TOPAMAX TABLETS
compare
TREXIMET
compare
ZOMIG
compare
ZOMIG NASAL SPRAY
compare
ZOMIG-ZMT
compare
Most Popular
Most Emailed
Most Recent
FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates
Kapidex to be marketed under new trade name Dexilant
Hizentra approved for primary immunodeficiency
Xiaflex available for Dupuytren's contracture
Trelstar 22.5mg approved for palliative treatment of prostate cancer
Pediaderm HC Complete Kit available for atopic dermatitis
New Product: SAPHRIS
®
(asenapine) Sublingual Tablets
Botox approved for upper limb spasticity
FDA halts marketing of unapproved nitroglycerin tablets
FDA accepts NDA for lurasidone, a treatment for schizophrenia
FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates
Recommended Adult Immunization Schedule
Prevnar 13 pneumococcal disease vaccine approved
Xiaflex available for Dupuytren's contracture
Hizentra approved for primary immunodeficiency
Kapidex to be marketed under new trade name Dexilant
Ampyra available for multiple sclerosis patients
FDA grants priority review to Tasigna for newly diagnosed chronic myeloid leukemia
FDA accepts NDA for JZP-6, a treatment for fibromyalgia
Rituxan approved for chronic lymphocytic leukemia
FDA halts marketing of unapproved nitroglycerin tablets
Hibiclens General Skin Cleansing Patient Kit available
Bowel Cleansers
Neosalus Cream available for dermatitis
FDA warns of reduced Plavix efficacy in poor metabolizers
Five-day dosing regimen for Dacogen approved for myelodysplastic syndromes (MDS)
FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates
Trelstar 22.5mg approved for palliative treatment of prostate cancer
FDA accepts NDA for lurasidone, a treatment for schizophrenia
FDA warns of intravascular hemolysis risk with WinRho SDF
Sponsored Links